Selective Inhibition of HDAC1 and HDAC2 as a Potential Therapeutic Option for B-ALL

av Stubbs, Matthew C., Kim, Wonil, Bariteau, Megan, Davis, Tina, Vempati, Sridhar, Minehart, Janna, Witkin, Matthew, Qi, Jun, Krivtsov, Andrei V., Bradner, James E., Kung, Andrew L., Armstrong, Scott A.
I publikationen Clin Cancer Res (2015)

H3K79 methylation profiles define murine and human MLL-AF4 leukemias

av Krivtsov, Andrei V., Feng, Zhaohui, Lemieux, Madeleine E., Faber, Joerg, Vempati, Sridhar, Sinha, Amit U., Xia, Xiaobo, Jesneck, Jonathan, Bracken, Adrian P., Silverman, Lewis B., Kutok, Jeffery L., Kung, Andrew L., Armstrong, Scott A.
Publicerad 2008

MLL-rearranged Leukemia is Dependent on Aberrant H3K79 Methylation by DOT1L

av Bernt, Kathrin M., Zhu, Nan, Sinha, Amit U., Vempati, Sridhar, Faber, Joerg, Krivtsov, Andrei V., Feng, Zhaohui, Punt, Natalie, Daigle, Amanda, Bullinger, Lars, Pollock, Roy M., Richon, Victoria M., Kung, Andrew L., Armstrong, Scott A.
Publicerad 2011